Tag | Content |
---|
EnhancerAtlas ID | HS133-08920 |
Organism | Homo sapiens |
Tissue/cell | melanoma |
Coordinate | chr13:114301130-114302950 |
Target genes | |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
E2F6 | MA0471.1 | chr13:114302067-114302078 | CTTTCCCGCCC | - | 6.32 | NR2C2 | MA0504.1 | chr13:114301751-114301766 | TCACCTCTGACCTCT | - | 6.88 | NR2C2 | MA0504.1 | chr13:114301758-114301773 | TGACCTCTGACCTTC | - | 7.33 | Nr2f6 | MA0677.1 | chr13:114301758-114301772 | TGACCTCTGACCTT | - | 7.28 | Rxra | MA0512.2 | chr13:114301758-114301772 | TGACCTCTGACCTT | - | 6.62 |
|
| Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
SE_41872 | chr13:114301246-114302949 | LNCaP |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 2 | Chromosome | Start | End |
chr13 | 114301674 | 114302571 | chr13 | 114301802 | 114302224 |
|
| Number: 2 | ID | Chromosome | Start | End |
GH13I113646 | chr13 | 114300486 | 114301165 | GH13I113647 | chr13 | 114301216 | 114302896 |
|
Enhancer Sequence | TAGAAGGTAT GAAGGAGAGC TAAGTGTTTT ATTTGAGTTG GCTAAATCAA TCACTGAAAA 60 TTCCAATAGA AGACTAGTTT TAGAAGAATC ATTTTTTCCT AATCTTGAAT TACCATAAGC 120 ATATCGAGGG TTGTGGAACT TACATAAAAC TACGGGCAGT CGTGCCTCAG AGGGCTCTGT 180 GTGGGTGCAT GTGCAGCCAG CACCTGCGGG TGCACCGTGG CTTCCCGTGG CGAGCTTCCT 240 GTGCCTGTGT TTCTTCCAGG CCTTGGGGGT TGAAACTCAG GGCTGGTGAT TCTGAAGGGT 300 GGGGCAGGAG CAGCCCCCGG CTTTATCAGG AAGGGGCTCT GATCGGGCAC GGGGGTGCCC 360 CTGTGGGTGG GATTGCTGGA GCCCAGGACA TCAAGGCCAG CCTGGGCAGC ATAGAGAGAC 420 CCTGCCTCTG AAGAAAGAGT GGGGCTCTGG TGTCCATGGA GAGTCTGGGG AGGGAGGAAG 480 AGGCTAGGGT TCTGAGGGCC TGGAGATGGG GGCTCTGGGT GGCCATGGGA CACGTGGCAG 540 GCGTGTTGGG TTCCAGCTGG GTTGGCTTTG AGAGTCTGGT GGGATGAACC CTCATGGCTC 600 CACCGTCACT TTGAGGTGGT GTCACCTCTG ACCTCTGACC TTCAGCATGG CATGACCTCG 660 CTGAGGTGAC CCTGGTGTCC CACATATCAC CCTGAGTGTT CTTAATACAC AGTCGAGGGC 720 TGTGTTCATT GGACTATTCT GGTGTCACCG CCCACTTCAT TTCTGTGCCT GGCAGCACTT 780 TTACTCCTGG TTGGGAGCAT GACCGCCTCC CAGTTCAGCT TCCTCCTGCG TCCCAAGTGA 840 GCGGGGCGGC TGTCCTCGAG GACTCCGGGC TCACAGCCAA CCTGCTGGCA CGGCTCGAGG 900 ACTCCGGGCT CACAGCCAAC CTGCTGGCAC GGCCGCCCTT TCCCGCCCTG CCTCGGGTGA 960 GCCAAGGACT TGTCTTCTGC TTCCTGGGTT CCTGAAAGAG CTCTCCTCTG ATTTCTCAAA 1020 GGCAAAATAA AACTCAGATT TAAGTCTTTG GTGCGTAGCC CCTAATTTCC TTCCCTTTCT 1080 CTGAATCCTC ACTGCCCAGC ATGATGGACC GGCCTGGGCT CAGGACCTGA TTCCACAGGC 1140 TCCCAGCCCT CCCACAGGTA CCGTGTCTTC TGTGCTGGTG TCGCACCCGC CGGCCACCGC 1200 CACCCTGCGT CTTAGACGTC CCGCCGCAGC TGTGTTTCCA CCTCATCTCC AGCTTGAGTG 1260 GCAGCCAGCG GCGCCACCTG CACACGAGCC CCCTCCATTC GAGAAGCACA GACTATGAGT 1320 GTGGCCACGC GTCCCATGAC GTGAACTCAC GTCTGCGCCG AGACCTTTGC CGGCGGTTTT 1380 TTACTGACGG AGTAAGCACT GGAGATGCTT GGTACAGCGT CTTCCATCGG TAAATTGATT 1440 TAGTTAACCT TACAACATAT CTGCAAGGTT TTTAATCTTT CTTCCAAGAC CGTTTCTCAT 1500 GGACTTTTCT GTGTGTCTGT TGGGGGCTGA CGGACTTCGA CGCGCCAGTC GCTTGTGCTT 1560 GGGGCCCTTT GGGTACTAAC AGCCACACTG CTGAGCATGT GAAATCAGGA CCCAGGCTGC 1620 ACACCGCCGT CGGGGTGAGA CGCCCGTGGC CTTGCATGAT GAAACTGGGA CCCAGGCCTC 1680 ACTGCTGTCT GGGTGAGAAG TCTGTGGCCT TCAGCAAGAG CAGGTTTGCT TGTTTGGGAG 1740 AATGTTCTCA TTTCAGTTTT TTGAAAGGGT TAGAGCTGCT AACTTAACAT TTATATTTGG 1800 AGGAGAGACT TGTTCTTGGT 1820
|